Evidence map›Paper›PMID 29357090›Full record

ArticleJournal of neuro-oncology2018

Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.

Yung-Chiang Liu, I-Chi Lee, Pin-Yuan Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yung-Chiang LiuPh.D. Program in Biomedical Engineering, Chang Gung University, Taoyuan, 33302, Taiwan.
I-Chi LeeGraduate Institute of Biochemical and Biomedical Engineering, Chang Gung University, No. 259, Wenhua 1st Rd., Guishan Dist., Taoyuan, 33302, Taiwan. iclee@mail.cgu.edu.tw.ORCID http://orcid.org/0000-0001-6527-0077
Pin-Yuan ChenDepartment of Neurosurgery, Chang Gung Memorial Hospital, Linkou, 33305, Taiwan. pinyuanc@gmail.com.
Chang Gung University · TWChang Gung University of Science and Technology · TW

Funding

Chang Gung Memorial Hospital, Linkou CMRPD1E0141-2Chang Gung Memorial Hospital, Linkou CMRPD1E0361-2Chang Gung Memorial Hospital, Linkou CMRPG3D1343Ministry of Science and Technology, Taiwan 105-2314-B-182-007
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most malignant primary brain tumor and contains tumorigenic cancer stem cells (CSCs), which support the progression of tumor growth. The selection of CSCs and facilitation of the brain tumor niches may assist the development of novel therapeutics for GBM. Herein, hydrogel materials composed of agarose and hydroxypropyl methyl cellulose (HMC) in different concentrations were established and compared to emulate brain tumor niches and CSC microenvironments within a label-free system. Human GBM cell line, U-87 MG, was cultured on a series of HMC-agarose based culture system. Cell aggregation and spheroids formation were investigated after 4 days of culture, and 2.5% HMC-agarose based culture system demonstrated the largest spheroids number and size. Moreover, CD133 marker expression of GBM cells after 6 days of culture in 2.5% HMC-agarose based culture system was 60%, relatively higher than the control group at only 15%. Additionally, cells on 2.5% HMC-agarose based culture system show the highest chemoresistance, even at the high dose of 500 µM temozolomide for 72 h, the live cell ratio was still > 80%. Furthermore, the results also indicate that the expression of ABCG2 gene was up-regulated after culture in 2.5% HMC-agarose based culture system. Therefore, our results demonstrated that biomimetic brain tumor microenvironment may regulate GBM cells towards the CSC phenotype and expression of CSC characteristics. The microenvironment selection and spheroids formation in HMC-agarose based culture system may provide a label-free CSC selection strategy and drug testing model for future biomedical applications.

Indexed as

Brain NeoplasmsGlioblastomaNeoplastic Stem CellsStem Cell NicheTissue EngineeringTumor MicroenvironmentAC133 AntigenAntineoplastic Agents, AlkylatingApoptosisCell Line, TumorCell SurvivalDrug Resistance, NeoplasmDrug Screening Assays, AntitumorHumansHydrogelsHypromellose DerivativesAC133 AntigenAntineoplastic Agents, AlkylatingHydrogelsHypromellose DerivativesPROM1 protein, humanSepharoseTemozolomideBrain tumor nicheCancer stem cells (CSCs)Drug resistanceHuman glioblastoma cellsHydroxypropyl methyl cellulose (HMC)

Identifiers

PMID29357090
OpenAlexW2785101803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.